Psychological adjustment to chronic disease

The Lancet

Volumn 372, Issue 9634, 2008, Pages 246-255

  de Ridder, Denise ^a   Geenen, Rinie ^a   Kuijer, Roeline ^a   van Middendorp, Henriët ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADJUSTMENT; BEHAVIOR; CHRONIC DISEASE; COGNITION; COGNITIVE THERAPY; DAILY LIFE ACTIVITY; EMOTIONALITY; FATIGUE; HUMAN; MOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SELF CARE;

EID: 47149103344     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61078-8     Document Type: Review

References (142)

1. Sprangers M., de Regt E., Andries F., et al. Which chronic conditions are associated with better or poorer quality of life?. J Clin Epidemiol 53 (2000) 895-907
2. Taylor S., and Aspinwall L. Psychosocial aspects of chronic illness. In: Costa P., and VandenBos G. (Eds). Psychological aspects of serious illness: chronic conditions, fatal diseases, and clinical care (1996), American Psychological Association, Washington, DC 7-60
3. Maes S., Leventhal H., and de Ridder D. Coping with chronic disease. In: Zeidner M., and Endler N. (Eds). Handbook of coping: theory, research, applications (1996), Wiley, New York 221-251
4. Stanton A., Collins C., and Sworowski L. Adjustment to chronic illness: theory and research. In: Baum A., Revenson T., and Singer J. (Eds). Handbook of health psychology (2001), Erlbaum, Mahwah, NJ 387-403
5. Taylor S. Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol 38 (1983) 1161-1173
6. Adler N., and Matthews K. Health psychology. Why do some people get sick and some stay well?. Annu Rev Psychol 45 (1994) 229-259
7. Cameron L., and Leventhal H. Self-regulation, health, and illness. An overview. In: Cameron L., and Leventhal H. (Eds). The self-regulation of health and illness behaviour (2003), Routledge, New York 1-13
8. Sharpe L., and Curran L. Understanding the process of adjustment to illness. Soc Sci Med 62 (2006) 1153-1166
9. Walker J., Jackson H., and Littlejohn G. Models of adjustment to chronic illness: using the example of rheumatoid arthritis. Clin Psychol Rev 24 (2004) 461-488
10. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933 (2001) 222-234
11. Janszky I., Lekander M., Blom M., Georgiades A., and Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 19 (2005) 555-563
12. Musselman D., Betan E., Larsen H., and Phillips L. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54 (2003) 317-329
13. Lee B., Dantzer R., Langley K., et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomod 11 (2004) 279-292
14. Malik U., Makower D., and Wadler S. Interferon-mediated fatigue. Cancer 92 (2001) 1664-1668
15. Raison C., Demetrashvili M., Capuron L., and Miller A. Neuropsychiatric adverse effects of interferon-alpha. Recognition and management. CNS Drugs 19 (2005) 105-123
16. Schaefer M., Engelbrecht M., Gut O., et al. Interferon alpha (IFN alpha) and psychiatric syndromes. A review. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 731-746
17. Trask P., Paterson A., Esper P., Pau J., and Redman B. Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psycho-Oncol 13 (2004) 526-536
18. Durez P., Toukap A., Lauwerys B., et al. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Ann Rheum Dis 63 (2004) 1069-1074
19. Genovese M., Bathon J., Fleischmann R., et al. Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis. J Rheumatol 32 (2005) 1232-1242
20. Heiberg M., Nordvag B., Mikkelsen K., et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis. A six-month, longitudinal, observational, multicenter study. Arthritis Rheum 52 (2005) 2506-2512
21. Kosinski M., Kujawski S., Martin R., et al. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. Am J Manag Care 8 (2002) 231-240
22. Lipsky P., van der Heijde D., St Clair E., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343 (2000) 1594-1602
23. Maini R., Breedveld F., Kalden J., et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50 (2004) 1051-1065
24. Moreland L., Schiff M., Baumgartner S., et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130 (1999) 478-486
25. Quinn M., Conaghan P., O'Connor P., et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal. Results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 (2005) 27-35
26. Russell A., Conner-Spady B., Mintz A., Mallon C., and Maksymowych W. The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab. J Rheumatol 30 (2003) 941-947
27. Sany J., Kaiser M., Jorgensen C., and Trape G. Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis. Ann Rheum Dis 64 (2005) 1647-1649
28. St Clair E., van der Heijde D., Smolen J., et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum 50 (2004) 3432-3443
29. Weinblatt M., Keystone E., Furst D., et al. Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate. The ARMADA trial. Arthritis Rheum 48 (2003) 35-45
30. Vlaeyen J., and Morley S. Active despite pain: the putative role of stop-rules and current mood. Pain 110 (2004) 512-516
31. Smith R., and Polley H. Rest therapy for rheumatoid arthritis. Mayo Clin Proc 53 (1978) 141-145
32. de Jong Z., Munneke M., Zwinderman A., et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 48 (2003) 2415-2424
33. Smidt N., de Vet H., Bouter L., and Dekker J. Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother 51 (2005) 71-85
34. Gross J. The emerging field of emotion regulation: an integrative review. Rev Gen Psychol 2 (1998) 271-299
35. Austenfeld J., and Stanton A. Coping through emotional approach: a new look at emotion, coping, and health-related outcomes. J Pers 72 (2004) 1335-1364
36. Garssen B. Repression: finding our way in the maze of concepts. J Behav Med 30 (2007) 471-481
37. Solano L., Montella F., Salvati S., et al. Expression and processing of emotions: relationships with CD4+ levels in 42 HIV-positive asymptomatic individuals. Psychol Health 16 (2001) 689-698
38. Hirokawa K., Nagata C., Takatsuka N., and Shimizu H. The relationships of a rationality/antiemotionality personality scale to mortalities of cancer and cardiovascular disease in a community population in Japan. J Psychosom Res 56 (2004) 103-111
39. Iwamitsu Y., Shimoda K., Abe H., Tani T., Okawa M., and Buck R. Anxiety, emotional suppression, and psychological distress before and after breast cancer diagnosis. Psychosomatics 46 (2005) 19-24
40. Van Middendorp H., Geenen R., Sorbi M., Van Doornen L., and Bijlsma J. Emotion regulation predicts change of perceived health in patients with rheumatoid arthritis. Ann Rheum Dis 64 (2005) 1071-1074
41. Hamilton N., Zautra A., and Reich J. Affect and pain in rheumatoid arthritis: do individual differences in affective regulation and affective intensity predict emotional recovery from pain?. Ann Behav Med 29 (2005) 216-224
42. Stanton A., Danoff-Burg S., Cameron C., et al. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol 68 (2000) 875-882
43. Zautra A., Smith B., Affleck G., and Tennen H. Examinations of chronic pain and affect relationships: applications of a dynamic model of affect. J Consult Clin Psychol 69 (2001) 786-795
44. Solano L., Costa M., Temoshok L., et al. An emotionally inexpressive (type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychol Health 17 (2002) 641-655
45. Weihs K., Enright T., Simmens S., and Reiss D. Negative affectivity, restriction of emotions, and site of metastases predict mortality in recurrent breast cancer. J Psychosom Res 49 (2000) 59-68
46. Reynolds P., Hurley S., Torres M., Jackson J., Boyd P., and Chen V. Use of coping strategies and breast cancer survival: results from the Black/White Cancer Survival Study. Am J Epidemiol 152 (2000) 940-949
47. Tijhuis M., Elshout J., Feskens E., Janssen M., and Kromhout D. Prospective investigation of emotional control and cancer risk in men (the Zutphen Elderly Study) (The Netherlands). Cancer Causes Control 11 (2000) 589-595
48. Giraldi T., Rodani M., Cartei G., and Grassi L. Psychosocial factors and breast cancer: a 6-year Italian follow-up study. Psychother Psychosom 66 (1997) 229-236
49. Goodwin P., Ennis M., Bordeleau L., et al. Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22 (2004) 4184-4192
50. Watson M., Haviland J., Greer S., Davidson J., and Bliss J. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354 (1999) 1331-1336
51. Kelley J., Lumley M., and Leisen J. Health effects of emotional disclosure in rheumatoid arthritis patients. Health Psychol 16 (1997) 331-340
52. Stanton A., Danoff-Burg S., Sworowski L., et al. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J Clin Oncol 20 (2002) 4160-4168
53. Warner L., Lumley M., Casey R., et al. Health effects of written emotional disclosure in adolescents with asthma: a randomized, controlled trial. J Pediatr Psychol 31 (2006) 557-568
54. Wetherell M., Byrne-Davis L., Dieppe P., et al. Effects of emotional disclosure in psychological and physiological outcomes in patients with rheumatoid arthritis: an exploratory home-based study. J Health Psychol 10 (2005) 277-285
55. Zakowski S., Ramati A., Morton C., Johnson P., and Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Health Psychol 23 (2004) 555-563
56. Broderick J., Stone A., Smyth J., and Kaell A. The feasibility and effectiveness of an expressive writing intervention for rheumatoid arthritis via home-based videotaped instructions. Ann Behav Med 27 (2004) 50-59
57. De Moor C., Sterner J., Hall M., et al. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychol 21 (2002) 615-619
58. Hockemeyer J., and Smyth J. Evaluating the feasibility and efficacy of a self-administered manual-based stress management intervention for individuals with asthma: results from a controlled study. Behav Med 27 (2002) 161-172
59. Rosenberg H., Rosenberg S., Ernstoff M., et al. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatr Med 32 (2002) 37-53
60. Taylor L., Wallander J., Anderson D., Beasley P., and Brown R. Improving health care utilization, improving chronic disease utilization, health status, and adjustment in adolescents and young adults with cystic fibrosis: a preliminary report. J Clin Psychol Med Settings 10 (2003) 9-16
61. Walker B., Nail L., and Croyle R. Does emotional expression make a difference in reactions to breast cancer?. Oncol Nurs Forum 26 (1999) 1025-1032
62. Petrie K., Fontanilla I., Thomas M., Booth R., and Pennebaker J. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med 66 (2004) 272-275
63. Smyth J., Stone A., Hurewitz A., and Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. JAMA 281 (1999) 1304-1309
64. Harris A., Thoresen C., Humphreys K., and Faul J. Does writing affect asthma? A randomized trial. Psychosom Med 67 (2005) 130-136
65. Giese-Davis J., Koopman C., Butler L., et al. Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. J Consult Clin Psychol 70 (2002) 916-925
66. Pennebaker J. Health effects of the expression (and non-expression) of emotions through writing. In: Vingerhoets A., Van Bussel F., and Boelhouwer J. (Eds). The (non)expression of emotions in health and disease (1997), Tilburg University Press, Tilburg 267-278
67. Wiebe D., and Korbel C. Defensive denial, affect, and the self-regulation of health threats. In: Cameron L., and Leventhal H. (Eds). The self-regulation of health and illness behaviour (2003), Routledge, New York 184-203
68. Mauss I., and Gross J. Emotion suppression and cardiovascular disease: is hiding feelings bad for your heart?. In: Temoshok L., Nyklicek I., and Vingerhoets A. (Eds). Emotions in health promotion and disease (2004), Harwood Academic Press, London 61-81
69. Lutgendorf S., and Ullrich P. Cognitive processing, disclosure, and health: psychological and physiological mechanisms. In: Lepore S., and Smyth J. (Eds). The writing cure: how expressive writing promotes health and emotional well-being (2002), American Psychological Association, Washington, DC 177-196
70. Manne S., Ostroff J., Winkel G., Goldstein L., Fox K., and Grana G. Posttraumatic growth after breast cancer: patient, partner, and couple perspectives. Psychosom Med 66 (2004) 442-454
71. Barlow J., Wright C., Sheasby J., Turner A., and Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 48 (2002) 177-187
72. Collins R., Kanouse D., Gifford A., et al. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol 20 (2001) 351-360
73. Riemsma R., Taal E., Kirwan J., and Rasker J. Systematic review of rheumatoid arthritis patient education. Arthritis Rheum 51 (2004) 1045-1059
74. Bailey W., Kohler C., Richards J., et al. Asthma self-management. Do patient education programs always have an impact?. Arch Intern Med 159 (1999) 2422-2428
75. Williams G., McGregor H., Zeldman A., Freedman Z., and Deci E. Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Health Psychol 23 (2004) 58-66
76. Jaarsma T., Halfens R., Tan F., Abu-Saad H., Dracup K., and Diederiks J. Self-care and quality of life in patients with advanced heart failure: the effect of a supportive educational intervention. Heart Lung 29 (2000) 319-330
77. Dunbar-Jacob J., and Mortimer-Stephens M. Treatment adherence in chronic disease. J Clin Epidemiol 54 (2001) S57-S60
78. Gillibrand W., and Flynn M. Forced externalization of control in people with diabetes: a qualitative exploratory study. J Adv Nurs 34 (2001) 501-510
79. Weijman I., Ros W., Rutten G., Schaufeli W., Schabracq M., and Winnubst J. Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes. Diabetes Res Clin Pract 68 (2005) 56-64
80. Lin E., Katon W., von Korff M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27 (2004) 2154-2160
81. Safford M., Russell L., Suh D., Roman S., and Pogach L. How much time do patients with diabetes spend on self-care?. J Am Board Fam Pract 18 (2005) 262-270
82. DiMatteo M., Lepper H., and Croghan T. Depression is a risk factor for noncompliance with medical treatment. Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
83. Peyrot M., and Rubin R. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20 (1997) 585-590
84. Dowson C., Town G., Frampton C., and Mulder R. Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res 56 (2004) 333-340
85. Fehr J., Nicca D., Sendi P., et al. Starting or changing therapy. A prospective study exploring antiretroviral decision-making. Infection 33 (2005) 249-256
86. Lustman P., Freedland K., Griffith L., and Clouse R. Fluoxetine for depression in diabetes. A randomized double-blind placebo-controlled trial. Diabetes Care 23 (2000) 618-623
87. Lustman P., Clouse R., Ciechanowski P., Hirsch I., and Freedland K. Depression-related hyperglycemia in type 1 diabetes: a mediational approach. Psychosom Med 67 (2005) 195-199
88. Polonsky W. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 13 (2000) 36-41
89. Polonsky W., Anderson B., Lohrer P., et al. Assessment of diabetes-related distress. Diabetes Care 18 (1995) 754-760
90. Katz P., Eisner M., Yelin E., et al. Functioning and psychological status among individuals with COPD. Qual Life Res 14 (2005) 1835-1843
91. Lloyd C., Dyer P., Lancashire R., Harris T., Daniels J., and Barnett A. Association between stress and glycemic control in adult with type 1 (insulin-dependent) diabetes. Diabetes Care 22 (1999) 1278-1283
92. Main J., Moss-Morris R., Booth R., Kaptein A., and Kolbe J. The use of reliever medication in asthma: the role of negative mood and symptom reports. J Asthma 40 (2003) 357-365
93. Lev E., Paul D., and Owen S. Age, self-efficacy, and change in patients' adjustment to cancer. Cancer Pract 7 (1999) 170-176
94. Katz P., and Yelin E. Activity loss and the onset of depressive symptoms. Do some activities matter more than others?. Arthritis Rheum 44 (2001) 1194-1202
95. Senecal C., Nouwen A., and White D. Motivation and dietary self-care in adults with diabetes: are self-efficacy and autonomous self-regulation complementary or competing constructs?. Health Psychol 19 (2000) 452-457
96. Dropkin M. Anxiety, coping strategies, and coping behaviors in patients undergoing head and neck cancer surgery. Cancer Nurs 24 (2001) 143-148
97. Mock V., Pickett M., Ropka M., et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9 (2001) 119-127
98. Jaarsma T., Halfens R., Abu-Saad H., Dracup K., Stappers J., and van Ree J. Quality of life in older patients with systolic and diastolic heart failure. Eur J Heart Fail 1 (1999) 151-160
99. Ai A., Dunkle R., Peterson C., Saunders D., and Bolling S. Self-care and psychosocial adjustment of patients following cardiac surgery. Soc Work Health Care 27 (1998) 75-95
100. de Ridder D., and Schreurs K. Developing interventions for chronically ill patients: is coping a helpful concept?. Clin Psychol Rev 21 (2001) 205-240
101. Walker C., Weeks A., McAvoy B., and Demetriou E. Exploring the role of self-management programmes in caring for people from culturally and linguistically diverse backgrounds in Melbourne, Australia. Health Expect 8 (2005) 315-323
102. Polonsky W. Diabetes burnout (1999), American Diabetes Association, Alexandria, VA
103. van't Spijker A., Trijsburg R., and Duivenvoorden H. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59 (1997) 280-293
104. Leventhal H., Brisette I., and Leventhal E. The common-sense model of self-regulation of health and illness. In: Cameron L., and Leventhal H. (Eds). The self-regulation of health and illness behaviour (2003), Routledge, London 42-65
105. Skinner T., Hampson S., and Fife-Schaw C. Personality, personal model beliefs, and self-care in adolescents and young adults with Type 1 diabetes. Health Psychol 21 (2002) 61-70
106. Affleck G., and Tennen H. Construing benefits from adversity: adaptational significance and dispositional underpinnings. J Pers 64 (1996) 899-922
107. Janoff-Bulman R. Posttraumatic growth: three explanatory models. Psychol Inq 15 (2004) 30-34
108. Tedeschi R., and Calhoun L. Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq 15 (2004) 1-18
109. Sprangers M., and Schwartz C. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48 (1999) 1507-1515
110. Antoni M., Lehman J., Kilbourn K., et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20 (2001) 20-32
111. Bower J., Meyerowitz B., Desmond K., Bernaards C., Rowland J., and Ganz P. Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors. Ann Behav Med 29 (2005) 236-245
112. Petrie K., Buick D., Weinman J., and Booth R. Positive effects of illness reported by myocardial infarction and breast cancer patients. J Psychosom Res 47 (1999) 537-543
113. Sears S., Stanton A., and Danoff-Burg S. The yellow brick road and the emerald city: benefit finding, positive reappraisal coping, and posttraumatic growth in women with early-stage breast cancer. Health Psychol 22 (2003) 487-497
114. Tomich P., and Helgeson V. Is finding something good in the bad always good? Benefit finding among women with breast cancer. Health Psychol 23 (2004) 16-23
115. Andrykowski M., Bishop M., Hahn E., et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23 (2005) 599-608
116. Widows M., Jacobsen P., Booth-Jones M., and Fields K. Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol 24 (2005) 266-273
117. Danoff-Burg S., and Revenson T. Benefit-finding among patients with rheumatoid arthritis: positive effects on interpersonal relationships. J Behav Med 28 (2005) 91-103
118. Pakenham K. Benefit finding in multiple sclerosis and associations with positive and negative outcomes. Health Psychol 24 (2005) 123-132
119. Siegel K., and Schrimshaw E. Perceiving benefits in adversity: stress-related growth in women living with HIV/AIDS. Soc Sci Med 51 (2000) 1543-1554
120. Andrykowski M., Curran S., Studts J., et al. Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems-a controlled comparison. J Clin Epidemiol 49 (1996) 827-834
121. Tomich P., Helgeson V., and Vache E.N. Perceived growth and decline following breast cancer: a comparison to age-matched controls 5-years later. Psycho-Oncol 14 (2005) 1018-1029
122. Evers A., Kraaimaat F., van Lankveld W., Jongen P., Jacobs J., and Bijlsma J. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 69 (2001) 1026-1036
123. Lechner S., Zakowski S., Antoni M., Greenhawt M., Block K., and Block P. Do sociodemographic and disease-related variables influence benefit-finding in cancer patients?. Psycho-Oncol 12 (2003) 491-499
124. Carver C., and Antoni M. Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5 to 8 years after diagnosis. Health Psychol 23 (2004) 595-598
125. Bower J., Kemeny M., Taylor S., and Fahey J. Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol 66 (1998) 979-986
126. Affleck G., Tennen H., Croog S., and Levine S. Causal attribution, perceived benefits, and morbidity after a heart attack: an 8-year study. J Consult Clin Psychol 55 (1987) 29-35
127. McGregor B., Antoni M., Boyers A., Alferi S., Blomberg B., and Carver C. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J Psychosom Res 56 (2004) 1-8
128. Cruess D., Antoni M., Kumar M., et al. Effects of stress management on testosterone levels in women with early-stage breast cancer. Int J Behav Med 8 (2001) 194-207
129. Cruess D., Antoni M., McGregor B., et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med 62 (2000) 304-308
130. Stanton A., Bower J., and Low C. Posttraumatic growth after cancer. In: Calhoun L., and Tedeschi R. (Eds). Handbook of posttraumatic growth: research and practice (2006), Erlbaum, Mahwah, NJ
131. Ahmed S., Mayo N., Corbiere M., Wood-Dauphinee S., Hanley J., and Cohen R. Change in quality of life of people with stroke over time: true change or response shift?. Qual Life Res 14 (2005) 611-627
132. Schwartz C., Sprangers M., Carey A., and Reed G. Exploring response shift in longitudinal data. Psychol Health 19 (2004) 51-69
133. Sprangers M., van Dam F., Broersen J., et al. Revealing response shift in longitudinal research on fatigue. The use of the thentest approach. Acta Oncol 38 (1999) 709-718
134. Oort F., Visser M., and Sprangers M. An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery. Qual Life Res 14 (2005) 599-609
135. Bernhard J., Lowy A., Mathys N., Herrmann R., and Hurny C. Health related quality of life: a changing construct?. Qual Life Res 13 (2004) 1187-1197
136. Epping-Jordan J., Bengoa R., Kawar R., and Sabate E. The challenge of chronic conditions: WHO responds. BMJ 323 (2001) 947-948
137. Rothenberg R., and Koplan J. Chronic disease in the 1990s. Ann Rev Public Health 11 (1990) 267-296
138. Holland J., and Lewis S. The human side of cancer: living with hope, coping with uncertainty (2000), HarperCollins, New York
139. Holman H., and Lorig K. Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. BMJ 320 (2000) 526-527
140. Baumann L. Culture and illness representation. In: Cameron L., and Leventhal H. (Eds). The self-regulation of health and illness behaviour (2003), Routledge, New York 242-253
141. Roesch S., Adams L., Hines A., et al. Coping with prostate cancer: a meta-analytic review. J Behav Med 28 (2005) 281-293
142. Newman S., Steed L., and Mulligan K. Self-management interventions for chronic illness. Lancet 364 (2004) 1523-1537